Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


30.05.2022

1 Acta Neuropathol
3 Alzheimers Dement
1 Ann Neurol
3 Brain
17 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neurochem
1 J Neurosci
1 Nat Rev Neurol
5 Neurobiol Aging
1 Neurochem Res
4 Neurology
1 Neuropsychology
1 Neuroscience
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. LEE AJ, Raghavan NS, Bhattarai P, Siddiqui T, et al
    FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease.
    Acta Neuropathol. 2022 May 24. pii: 10.1007/s00401-022-02431.
    PubMed         Abstract available


    Alzheimers Dement

  2. LUO J, Thomassen JQ, Hegazy SH, Rasmussen IJ, et al
    Reply to "Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer's disease risk".
    Alzheimers Dement. 2022 May 22. doi: 10.1002/alz.12688.
    PubMed        

  3. HU Y, Zhang Y, Zhang H, Gao S, et al
    Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer's disease risk.
    Alzheimers Dement. 2022 May 22. doi: 10.1002/alz.12687.
    PubMed        

  4. VOGLEIN J, Franzmeier N, Morris JC, Dieterich M, et al
    Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease.
    Alzheimers Dement. 2022 May 24. doi: 10.1002/alz.12684.
    PubMed         Abstract available


    Ann Neurol

  5. BENUSSI A, Cantoni V, Grassi M, Brechet L, et al
    Increasing brain gamma activity improves episodic memory and restores cholinergic dysfunction in Alzheimer's disease.
    Ann Neurol. 2022 May 24. doi: 10.1002/ana.26411.
    PubMed         Abstract available


    Brain

  6. KO H, Kim S, Kim K, Jung SH, et al
    Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
    Brain. 2022;145:1436-1448.
    PubMed         Abstract available

  7. DUZEL E, Ziegler G, Berron D, Maass A, et al
    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
    Brain. 2022;145:1473-1485.
    PubMed         Abstract available

  8. TONIOLO S
    What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
    Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
    PubMed        


    J Alzheimers Dis

  9. TANCHEVA L, Lazarova M, Velkova L, Dolashki A, et al
    Beneficial Effects of Snail Helix aspersa Extract in an Experimental Model of Alzheimer's Type Dementia.
    J Alzheimers Dis. 2022 May 16. pii: JAD215693. doi: 10.3233/JAD-215693.
    PubMed         Abstract available

  10. HAO J, Guo Y, Guo K, Yang Q, et al
    Peripheral Inflammatory Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD215422. doi: 10.3233/JAD-215422.
    PubMed         Abstract available

  11. HOSSEINI AA, Brown T, Mannino L, Gran B, et al
    Clinical Utility of Cerebrospinal Fluid Abeta42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.
    J Alzheimers Dis. 2022;87:771-780.
    PubMed         Abstract available

  12. ZHANG R, Jiang L, Li G, Wu J, et al
    Advanced Glycosylation End Products Induced Synaptic Deficits and Cognitive Decline Through ROS-JNK-p53/miR-34c/SYT1 Axis in Diabetic Encephalopathy.
    J Alzheimers Dis. 2022;87:843-861.
    PubMed         Abstract available

  13. GIRTLER N, Chincarini A, Brugnolo A, Doglione E, et al
    The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort.
    J Alzheimers Dis. 2022;87:887-899.
    PubMed         Abstract available

  14. LIU X, Yan J, Liu F, Zhou P, et al
    Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice.
    J Alzheimers Dis. 2022;87:873-886.
    PubMed         Abstract available

  15. SOLOMON V, Hafez M, Xian H, Harrington MG, et al
    An Association Between Saturated Fatty Acid-Containing Phosphatidylcholine in Cerebrospinal Fluid with Tau Phosphorylation.
    J Alzheimers Dis. 2022;87:609-617.
    PubMed         Abstract available

  16. MARTINEZ-HERRERA M, Figueroa-Gerstenmaier S, Lopez-Camacho PY, Millan-Pacheco C, et al
    Multiadducts of C60 Modulate Amyloid-beta Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies.
    J Alzheimers Dis. 2022;87:741-759.
    PubMed         Abstract available

  17. GRANGEON L, Paquet C, Guey S, Zarea A, et al
    Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Abeta42, and Abeta40 in Probable Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;87:791-802.
    PubMed         Abstract available

  18. SIVASARAVANAPARAN M, Olesen LO, Severino M, von Linstow CU, et al
    Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2022;87:685-699.
    PubMed         Abstract available

  19. GE X, Qiao Y, Choi J, Raman R, et al
    Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms.
    J Alzheimers Dis. 2022;87:557-568.
    PubMed         Abstract available

  20. ICHIMATA S, Yoshida K, Visanji NP, Lang AE, et al
    Patterns of Mixed Pathologies in Down Syndrome.
    J Alzheimers Dis. 2022;87:595-607.
    PubMed         Abstract available

  21. FRAME G, Schuller A, Smith MA, Crish SD, et al
    Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 May 18. pii: JAD220016. doi: 10.3233/JAD-220016.
    PubMed         Abstract available

  22. CHENG Y, Jian JM, He CY, Ren JR, et al
    The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-beta and Tau Levels in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 16. pii: JAD220126. doi: 10.3233/JAD-220126.
    PubMed         Abstract available

  23. HOILUND-CARLSEN PF, Revheim ME, Alavi A
    Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start.
    J Alzheimers Dis. 2022 May 16. pii: JAD220190. doi: 10.3233/JAD-220190.
    PubMed         Abstract available

  24. TSAI YL, Yen CT, Wang YF
    Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD220218. doi: 10.3233/JAD-220218.
    PubMed         Abstract available

  25. WITTFELD K, Raman MR, Conner SC, Aslam A, et al
    Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.
    J Alzheimers Dis. 2022 May 16. pii: JAD220356. doi: 10.3233/JAD-220356.
    PubMed         Abstract available


    J Am Geriatr Soc

  26. HILL JD, Schmucker AM, Siman N, Goldfeld KS, et al
    Emergency and post-emergency care of older adults with Alzheimer's disease/Alzheimer's disease related dementias.
    J Am Geriatr Soc. 2022 May 25. doi: 10.1111/jgs.17833.
    PubMed         Abstract available


    J Neurochem

  27. QIN YR, Ma CQ, Jiang JH, Wang DP, et al
    Artesunate restores mitochondrial fusion-fission dynamics and alleviates neuronal injury in Alzheimer's disease models.
    J Neurochem. 2022 May 21. doi: 10.1111/jnc.15620.
    PubMed         Abstract available


    J Neurosci


  28. Erratum: Larson et al., "Soluble alpha-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology".
    J Neurosci. 2022 May 26. pii: JNEUROSCI.0896-22.2022.
    PubMed        


    Nat Rev Neurol

  29. KNOPMAN D, Sano M, Feldman HH
    CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease.
    Nat Rev Neurol. 2022 May 20. pii: 10.1038/s41582-022-00672.
    PubMed        


    Neurobiol Aging

  30. JIANG L, Qin Y, Zhao YW, Zeng Q, et al
    PSEN1 G417S mutation in a Chinese pedigree causing early-onset parkinsonism with cognitive impairment.
    Neurobiol Aging. 2022;115:70-76.
    PubMed         Abstract available

  31. FULOPOVA B, Bennett W, Summers BS, Stuart KE, et al
    Cortical axon sub-population maintains density, but not turnover, of en passant boutons in the aged APP/PS1 amyloidosis model.
    Neurobiol Aging. 2022;115:29-38.
    PubMed         Abstract available

  32. TAN CH, Chew J, Zhang L, Gulyas B, et al
    Differential effects of white matter hyperintensities and regional amyloid deposition on regional cortical thickness.
    Neurobiol Aging. 2022;115:12-19.
    PubMed         Abstract available

  33. LAPOINT MR, Baker SL, Landau SM, Harrison TM, et al
    Rates of beta-amyloid deposition indicate widespread simultaneous accumulation throughout the brain.
    Neurobiol Aging. 2022;115:1-11.
    PubMed         Abstract available

  34. BROWN SSG, Mak E, Clare I, Grigorova M, et al
    Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down's syndrome.
    Neurobiol Aging. 2022;115:112-121.
    PubMed         Abstract available


    Neurochem Res

  35. EL-GANAINY SO, Soliman OA, Ghazy AA, Allam M, et al
    Intranasal Oxytocin Attenuates Cognitive Impairment, beta-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer's Disease: Interplay of ERK1/2/GSK3beta/Caspase-3.
    Neurochem Res. 2022 May 20. pii: 10.1007/s11064-022-03624.
    PubMed         Abstract available


    Neurology

  36. MOHANTY R, Ferreira D, Frerich S, Muehlboeck JS, et al
    Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Neurology. 2022 May 24. pii: WNL.0000000000200573.
    PubMed         Abstract available

  37. DUMURGIER J, Sabia S, Zetterberg H, Teunissen C, et al
    Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
    Neurology. 2022 May 26. pii: WNL.0000000000200735.
    PubMed         Abstract available

  38. XICOTA L, Gyorgy B, Grenier-Boley B, Lecoeur A, et al
    Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults.
    Neurology. 2022 May 23. pii: WNL.0000000000200544.
    PubMed         Abstract available

  39. MCGIRR A, Nathan S, Ghahremani M, Gill S, et al
    Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
    Neurology. 2022;98:e2132-e2139.
    PubMed         Abstract available


    Neuropsychology

  40. CECCHINI MA, Parra MA, Brazzelli M, Logie RH, et al
    Short-term memory conjunctive binding in Alzheimer's disease: A systematic review and meta-analysis.
    Neuropsychology. 2022 May 26. pii: 2022-64751-001. doi: 10.1037/neu0000825.
    PubMed         Abstract available


    Neuroscience

  41. LIANG F, Sun F, He B, Wang J, et al
    Treadmill Exercise Promotes Microglial beta-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice.
    Neuroscience. 2022;491:122-133.
    PubMed         Abstract available


    PLoS One

  42. ALI M, Sung YJ, Wang F, Fernandez MV, et al
    Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
    PLoS One. 2022;17:e0267298.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: